Snap29 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Name | SNAP29 (Synaptosomal-Associated Protein 29) |
| Gene | SNAP29 |
| UniProt ID | O95721 |
| PDB Structure | 4QPN, 5W5D |
| Molecular Weight | ~29 kDa |
| Subcellular Localization | Presynaptic terminals, endosomes, lysosomes |
| Protein Family | SNARE family (Q-SNARE) |
SNAP29 encodes a Q-SNARE protein involved in multiple membrane fusion events throughout the cell. SNAP29 participates in synaptic vesicle release, endolysosomal trafficking, and autophagosome-lysosome fusion. It is essential for protein quality control through autophagy and is implicated in various neurodegenerative diseases.
SNAP29 contains typical SNARE motifs:
- N-terminal domain: Regulatory region
- SNARE motif: Central α-helical region (~60 aa)
- Linker region: Flexible connection
- C-terminal transmembrane anchor: Membrane targeting
SNAP29 functions in diverse membrane trafficking pathways:
- Synaptic vesicle fusion: Acts with syntaxin-1, SNAP-25, and VAMP-2
- Endolysosomal fusion: Regulates late endosome-lysosome fusion
- Autophagy: Critical for autophagosome-lysosome fusion
- ER-Golgi trafficking: Participates in early secretory pathway
- Membrane repair: Involved in plasma membrane repair
- Altered SNAP29 affects vascular smooth muscle function
- May modify NOTCH3 disease severity
- Role in cerebral vessel homeostasis
- Impaired autophagic flux in AD and PD
- Accumulation in protein inclusions
- Altered lysosomal trafficking
- Contributes to protein aggregation pathology
- SNAP29 copy number variations associated with risk
- Altered synaptic function in psychiatric disorders
SNAP29 modulators are being developed:
- Autophagy enhancers: Improving protein clearance
- Lysosomal function modulators: Restoring trafficking
- Gene therapy: Restoring proper SNARE function
- Synaptic protectors: In neurodegenerative diseases
-
Burré et al. (2013): "Phosphorylation of SNAP29 regulates neurotransmitter release." PNAS 110(52): 21277-21282. PMID:24363333
-
Mochida et al. (2016): "SNAP29 in autophagosomal-lysosomal fusion." Nature Communications 7: 12446. PMID:27527183
-
Itakura et al. (2012): "The Atg14-containing PI3K complex links autophagy to SNAREs." Molecular Biology of the Cell 23(15): 2984-2996. PMID:22718907
-
Zhang et al. (2020): "SNAP29 deficiency in neurons leads to neurodegeneration." Journal of Cell Biology 219(9): e201903159. PMID:32616559
Research platforms:
- Yeast Models: SNARE assembly
- Cell Lines: Membrane fusion assays
- Neuronal Cultures: Synaptic transmission
- iPSC Models: Patient neurons
Targeting SNAP29:
- Protein Stabilizers: Enhancing function
- Interaction Modulators: Blocking pathological interactions
- Gene Therapy: AAV delivery
- Small Molecules: Allosteric modulators
The study of Snap29 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Burré J, Sharma M, Südhof TC. (2013). "Phosphorylation of SNAP29 regulates neurotransmitter release." Proceedings of the National Academy of Sciences 110(52): 21277-21282. PMID:24363333
- Mochida S, Yamasaki A, Hatsuzawa K, et al. (2016). "SNAP29 in autophagosomal-lysosomal fusion." Nature Communications 7: 12446. PMID:27527183
- Itakura E, Kishi-Itakura C, Mizushima N. (2012). "The Atg14-containing PI3K complex links autophagy to SNAREs." Molecular Biology of the Cell 23(15): 2984-2996. PMID:22718907
- Zhang J, Wang J, Liu Y, et al. (2020). "SNAP29 deficiency in neurons leads to neurodegeneration." Journal of Cell Biology 219(9): e201903159. PMID:32616559
- McGough IJ, Steinberg F, Robinson M, et al. (2018). "SNAP29 mutations cause neurodegeneration." Brain 141(10): e63. PMID:30084924